Clinical trial
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders…
NCT00244023 · SELARL du Dr Jacques BUVAT, Other · Completed
Key facts
| NCT number | NCT00244023 |
|---|---|
| Title | Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone |
| Official title | Double-Blind, Placebo Controlled Randomized Study of Co-Administering Testosterone With PDE5 Inhibitors in Patients Non-Responders to PDE5 Inhibitors Alone |
| Lead sponsor | SELARL du Dr Jacques BUVAT, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction, Hypogonadism |
| Intervention type | Drug, Other |
| Interventions | Testosterone gel, testosterone, placebo gel |
| Enrollment | 173 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Oct 25, 2005 |
| Last update posted | Aug 25, 2008 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: